250 related articles for article (PubMed ID: 21411665)
1. Regulation of the PMP22 gene through an intronic enhancer.
Jones EA; Lopez-Anido C; Srinivasan R; Krueger C; Chang LW; Nagarajan R; Svaren J
J Neurosci; 2011 Mar; 31(11):4242-50. PubMed ID: 21411665
[TBL] [Abstract][Full Text] [Related]
2. Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development.
Lopez-Anido C; Poitelon Y; Gopinath C; Moran JJ; Ma KH; Law WD; Antonellis A; Feltri ML; Svaren J
Hum Mol Genet; 2016 Jul; 25(14):3055-3069. PubMed ID: 27288457
[TBL] [Abstract][Full Text] [Related]
3. In vivo detection of Egr2 binding to target genes during peripheral nerve myelination.
Jang SW; LeBlanc SE; Roopra A; Wrabetz L; Svaren J
J Neurochem; 2006 Sep; 98(5):1678-87. PubMed ID: 16923174
[TBL] [Abstract][Full Text] [Related]
4. Dynamic regulation of Schwann cell enhancers after peripheral nerve injury.
Hung HA; Sun G; Keles S; Svaren J
J Biol Chem; 2015 Mar; 290(11):6937-50. PubMed ID: 25614629
[TBL] [Abstract][Full Text] [Related]
5. Distal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22.
Jones EA; Brewer MH; Srinivasan R; Krueger C; Sun G; Charney KN; Keles S; Antonellis A; Svaren J
Hum Mol Genet; 2012 Apr; 21(7):1581-91. PubMed ID: 22180461
[TBL] [Abstract][Full Text] [Related]
6. Direct regulation of myelin protein zero expression by the Egr2 transactivator.
LeBlanc SE; Jang SW; Ward RM; Wrabetz L; Svaren J
J Biol Chem; 2006 Mar; 281(9):5453-60. PubMed ID: 16373334
[TBL] [Abstract][Full Text] [Related]
7. Neuropathy-associated Egr2 mutants disrupt cooperative activation of myelin protein zero by Egr2 and Sox10.
LeBlanc SE; Ward RM; Svaren J
Mol Cell Biol; 2007 May; 27(9):3521-9. PubMed ID: 17325040
[TBL] [Abstract][Full Text] [Related]
8. Activation of Krox20 gene expression by Sox10 in myelinating Schwann cells.
Reiprich S; Kriesch J; Schreiner S; Wegner M
J Neurochem; 2010 Feb; 112(3):744-54. PubMed ID: 19922439
[TBL] [Abstract][Full Text] [Related]
9. Induction of myelin protein zero by early growth response 2 through upstream and intragenic elements.
Jang SW; Svaren J
J Biol Chem; 2009 Jul; 284(30):20111-20. PubMed ID: 19487693
[TBL] [Abstract][Full Text] [Related]
10. SWI/SNF enzymes promote SOX10- mediated activation of myelin gene expression.
Marathe HG; Mehta G; Zhang X; Datar I; Mehrotra A; Yeung KC; de la Serna IL
PLoS One; 2013; 8(7):e69037. PubMed ID: 23874858
[TBL] [Abstract][Full Text] [Related]
11. Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A.
Boutary S; Caillaud M; El Madani M; Vallat JM; Loisel-Duwattez J; Rouyer A; Richard L; Gracia C; Urbinati G; Desmaële D; Echaniz-Laguna A; Adams D; Couvreur P; Schumacher M; Massaad C; Massaad-Massade L
Commun Biol; 2021 Mar; 4(1):317. PubMed ID: 33750896
[TBL] [Abstract][Full Text] [Related]
12. Locus-wide identification of Egr2/Krox20 regulatory targets in myelin genes.
Jang SW; Srinivasan R; Jones EA; Sun G; Keles S; Krueger C; Chang LW; Nagarajan R; Svaren J
J Neurochem; 2010 Dec; 115(6):1409-20. PubMed ID: 21044070
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis of EGR2/SOX10 binding in myelinating peripheral nerve.
Srinivasan R; Sun G; Keles S; Jones EA; Jang SW; Krueger C; Moran JJ; Svaren J
Nucleic Acids Res; 2012 Aug; 40(14):6449-60. PubMed ID: 22492709
[TBL] [Abstract][Full Text] [Related]
14. The transcription factors Sox10 and Myrf define an essential regulatory network module in differentiating oligodendrocytes.
Hornig J; Fröb F; Vogl MR; Hermans-Borgmeyer I; Tamm ER; Wegner M
PLoS Genet; 2013 Oct; 9(10):e1003907. PubMed ID: 24204311
[TBL] [Abstract][Full Text] [Related]
15. Regulation of myelin-specific gene expression. Relevance to CMT1.
Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
[TBL] [Abstract][Full Text] [Related]
16. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves.
Maier M; Berger P; Nave KA; Suter U
Mol Cell Neurosci; 2002 May; 20(1):93-109. PubMed ID: 12056842
[TBL] [Abstract][Full Text] [Related]
17. Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neurons.
Maier M; Castagner F; Berger P; Suter U
Mol Cell Neurosci; 2003 Nov; 24(3):803-17. PubMed ID: 14664827
[TBL] [Abstract][Full Text] [Related]
18. Mitogen-activated protein kinase p38 regulates Krox-20 to direct Schwann cell differentiation and peripheral myelination.
Hossain S; de la Cruz-Morcillo MA; Sanchez-Prieto R; Almazan G
Glia; 2012 Jul; 60(7):1130-44. PubMed ID: 22511272
[TBL] [Abstract][Full Text] [Related]
19. Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A.
Perea J; Robertson A; Tolmachova T; Muddle J; King RH; Ponsford S; Thomas PK; Huxley C
Hum Mol Genet; 2001 May; 10(10):1007-18. PubMed ID: 11331611
[TBL] [Abstract][Full Text] [Related]
20. Functional dissection of the Oct6 Schwann cell enhancer reveals an essential role for dimeric Sox10 binding.
Jagalur NB; Ghazvini M; Mandemakers W; Driegen S; Maas A; Jones EA; Jaegle M; Grosveld F; Svaren J; Meijer D
J Neurosci; 2011 Jun; 31(23):8585-94. PubMed ID: 21653862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
